David Kandzari
Overview
Explore the profile of David Kandzari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
478
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mufarrih S, Qureshi N, Khan M, Kazimuddin M, Secemsky E, Bloch M, et al.
J Am Heart Assoc
. 2024 Aug;
13(16):e034910.
PMID: 39140334
Background: Despite optimal medical therapy, a significant proportion of patients' blood pressure remains uncontrolled. Catheter-based renal denervation (RDN) has been proposed as a potential intervention for uncontrolled hypertension. We conducted...
2.
Kedhi E, Windecker S, Latib A, Kirtane A, Kandzari D, Mehran R, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(5):100441.
PMID: 39131461
Background: Patients with diabetes mellitus (DM) are at a higher risk of ischemic events compared with patients without DM. Percutaneous coronary intervention (PCI) with the Resolute Onyx zotarolimus-eluting stent (ZES)...
3.
Epps K, Goel R, Mehran R, Kandzari D, Damluji A, Tehrani B, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Mar;
2(5).
PMID: 38469035
Background: How diabetes mellitus (DM), race/ethnicity, and sex impact ischemic events following coronary artery stent procedures is unknown. Methods: Using the PLATINUM Diversity and PROMUS Element Plus Post-Approval Pooled Study...
4.
Hemetsberger R, Mankerious N, Toelg R, Abdelghani M, Farhan S, Garcia-Garica H, et al.
Clin Res Cardiol
. 2023 Apr;
112(9):1278-1287.
PMID: 37062047
Background: Patients with atherothrombotic risk are at high hazard of ischemic events. Preventive medicine plays a major role in modifying their outcomes. Whether the choice of a BP-SES or DP-EES...
5.
Hemetsberger R, Abdelghani M, Toelg R, Garcia-Garcia H, Farhan S, Mankerious N, et al.
Clin Res Cardiol
. 2022 Feb;
111(7):795-805.
PMID: 35212802
Background: Patients undergoing complex percutaneous coronary intervention (PCI) are at higher risk of adverse outcomes, but data are scarce in the era of newer-generation coronary stents. Aim: We sought to...
6.
7.
Hemetsberger R, Abdelghani M, Toelg R, Mankerious N, Allali A, Garcia-Garcia H, et al.
J Am Heart Assoc
. 2021 May;
10(12):e019815.
PMID: 34056911
Background Percutaneous coronary intervention of calcified lesions was associated with worse outcomes in the era of bare-metal and first-generation drug-eluting stents. Data on percutaneous coronary intervention of calcified lesions with...
8.
Kandzari D, Hearne S, Kumar G, Sachdeva R, Adams G, Blossom B, et al.
Cardiovasc Revasc Med
. 2021 Mar;
35:85-90.
PMID: 33781677
Background: The Scoreflex NC scoring angioplasty catheter is designed with a short rapid-exchange tip distal to a non-compliant, high-pressure balloon and an integral wire outside of the balloon, such that...
9.
Bohm M, Townsend R, Kario K, Kandzari D, Mahfoud F, Weber M, et al.
Clin Res Cardiol
. 2020 Apr;
109(5):653.
PMID: 32270345
The original version of this article unfortunately contained a mistake.
10.
Bohm M, Townsend R, Kario K, Kandzari D, Mahfoud F, Weber M, et al.
Clin Res Cardiol
. 2020 Feb;
109(3):289-302.
PMID: 32034481
Background: The SPYRAL HTN clinical trial program was initiated with two 80-patient pilot studies, SPYRAL HTN-OFF MED and SPYRAL HTN-ON MED, which provided biological proof of principle that renal denervation...